A single problem in vaccine improvement is financial: Lots of the health conditions most demanding a vaccine, like HIV, malaria and tuberculosis, exist principally in poor countries. Pharmaceutical companies and biotechnology firms have tiny incentive to build vaccines for these illnesses since There is certainly small earnings opportunity.Because